Elsevier

Ageing Research Reviews

Volume 62, September 2020, 101129
Ageing Research Reviews

Review
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing

https://doi.org/10.1016/j.arr.2020.101129Get rights and content

Highlights

  • Mitophagy is a major aspect in mitochondrial quality control.

  • Clinical and experimental data depicted a tie between ageing-related cardiovascular diseases and mitophagy failure.

  • Unchecked or deficient mitophagy compromises cardiovascular function in ageing.

  • Mitophagy inducer may be potential therapeutic agents in cardiovascular ageing.

Abstract

Mitophagy serves as a cardinal regulator in the maintenance of mitochondrial integrity, function, and cardiovascular homeostasis, through the fine control and governance of cellular metabolism, ATP production, redox balance, and mitochondrial quality and quantity control. As a unique form of selective autophagy, mitophagy specifically recognizes and engulfs long-lived or damaged (depolarized) mitochondria through formation of the double-membraned intracellular organelles - mitophagosomes, ultimately resulting in lysosomal degradation. Levels of mitophagy are reported to be altered in pathological settings including cardiovascular diseases and biological ageing although the precise nature of mitophagy change in ageing and ageing-associated cardiovascular deterioration remains poorly defined. Ample clinical and experimental evidence has depicted a convincing tie between cardiovascular ageing and altered mitophagy. In particular, ageing perturbs multiple enigmatic various signal machineries governing mitophagy, mitochondrial quality, and mitochondrial function, contributing to ageing-elicited anomalies in the cardiovascular system. This review will update novel regulatory mechanisms of mitophagy especially in the perspective of advanced ageing, and discuss how mitophagy dysregulation may be linked to cardiovascular abnormalities in ageing. We hope to pave the way for development of new therapeutic strategies against the growing health and socieconomical issue of cardiovascular ageing through targeting mitophagy.

Introduction

Biological ageing is an irreversible evolutionary process typically accompanied with a gradual accumulation of damaged organelles and metabolites, which undermines organismal function including cardiovascular and metabolic homeostasis, ultimately leading to cardiac remodeling (thickening of the left ventricular wall), diastolic prolongation, endothelial dysfunction, and other cardiovascular defects (Nair and Ren, 2012; Obas and Vasan, 2018; Ren et al., 2018; Wu and Ren, 2019; Xu et al., 2016; Zhang et al., 2017). Biological ageing process (hereafter being referred to as “ageing”) provokes various cardiovascular diseases through genomic instability, reactive oxygen species (ROS) overproduction, telomere degradation, lipotoxicity, apoptosis, and mitophagy dysregulation (Calcinotto et al., 2019; Ceylan-Isik et al., 2013; Hua et al., 2011; Ren and Zhang, 2019; Wang et al., 2018b; Xu et al., 2016; Zhang et al., 2014). Among these culprit factors for cardiovascular ageing, mitophagy, a highly conservative process in all eukaryotes to remove and recycle long-lived or damaged mitochondria, has drawn some recent attention (Ren and Zhang, 2018b). Mitophagy along with mitochondrial fission and fusion (collectively termed as mitochondrial dynamics) maintains mitochondrial homeostasis and governs reconstruction of mitochondria (Hernandez-Resendiz et al., 2020). Moreover, mitophagy retards mitochondrial apoptosis via neutralization/engulfment of impaired mitochondria (Ajoolabady et al., 2020; Wu et al., 2019b). A plethora of experimental evidence has demonstrated a role for defective mitophagy in the dysregulation of mitochondrial homeostasis and therefore myocardial function (Gustafsson and Dorn, 2019). Mitophagy perturbation is known to disturb genome integrity, arrests biogenesis of mitochondria, and generates ROS, leading to mitochondrial cell death in the hearts (Hernandez-Resendiz et al., 2020). Ageing is one of the main culprit factors which compromises mitophagy homeostasis to elicit mitochondrial damage in cardiovascular system (Gustafsson and Dorn, 2019; Ren and Zhang, 2018b; Zhou et al., 2017b; Zhou et al., 2018c). Mitochondrial fragmentation and compromised mitophagy are both well documented in aged cardiovascular system (Gustafsson and Dorn, 2019; Zhou et al., 2018c). Several core elements of mitophagy including PTEN-induced kinase 1 (PINK1) are downregulated in ageing, consolidating a likely ageing-associated decline in mitophagy (Ren et al., 2017; Zhou et al., 2017c). Moreover, advanced ageing may underlie the accumulation of certain mitophagy proteins in the heart due to mitophagy dysregulation (Thai et al., 2019). Hence, therapeutic maneuver targeting mitophagy should help to alleviate and repair ageing-induced mitophagy defects in the cardiovascular system (Ren et al., 2018), which would preserve mitochondrial homeostasis and cardiovascular health in the elderly. In this context, this review aims to delineate the most recent advances in the field of molecular mitophagy and to summarize possible strategies for therapeutics targeting mitophagy in an effort to preserve cardiac health in the relam of global ageing.

Section snippets

Mitochondrial integrity in cardiovascular ageing

Mitochondria are dynamic intracellular organelles encapsulated by two membrane structures namely mitochondrial outer membrane (MOM) and mitochondrial inner membrane (MIM). To share metabolites, proteins, and membranes, mitochondria interconnect with each other or with other organelles such as lysosomes and endoplasmic reticulum (ER) (Liu et al., 2020; Ren et al., 2010). Mitochondria undergo constant fusion and fission. Mitofusin1 (Mfn1) and Mfn2 carry out MOM fusion, while optic atrophy 1

PINK1/Parkin-mediated mitophagy in mammalian cells

Under physiological mitochondrial homeostasis, the mitophagy signal PINK1 is translocated to MIM, where it is cleaved by mitochondrial proteasomes. However, with mitochondrial damage or depolarization, PINK1 translocation is hampered, leading to its accumulation at MOM. PINK1 then recruits E3 ubiquitin ligase, Parkin, and prompts its phosphorylation/activation, ultimately ubiquitination of target mitochondrial proteins. Moreover, PINK1 phosphorylates ubiquitin chains, to further recruit Parkin,

Overview of mitophagy in neurodegenerative diseases

Mitochondrial impairment manifested by ROS accumulation, ATP reduction, mtDNA damage, caspase-mediated apoptosis, and mitophagy dysregulation is a cardinal contributor to Parkinson’s disease (PD). Mutations of several core mitophagy elements including sterol regulatory element-binding protein 1 (SREBF1), WD40 domain protein 7 (FBXW7), PINK1, Parkin, Parkinson disease protein 7 (DJ-1), leucine-rich repeat kinase 2 (LRRK2), and α-synuclein (α-Syn) impair mitophagy and mitochondrial function in

Mitophagy dysregulation in cardiovascular ageing

Ample evidence has denoted interconnections between impaired mitophagy and cardiovascular ageing. Deficiency in mitophagy promotes ageing process, while ageing dampens physiological activation and homeostasis of mitophagy (Yang et al., 2019a). Thai and coworkers reported accumulation of Parkin in aged cardiomyocytes and HF due to defective mitophagy (Thai et al., 2019), suggesting that ageing may be characterized by mitochondrial damages which initially evoke compensatory mitophagy.

Involvement of mitophagy in lifespan and longevity

Modulation of mitochondria offers a novel approach for lifespan extension and longevity in mammals. For example, induction of mild mitochondrial uncoupling (mMUC) in a tissue-specific manner has been suggested to promote longevity (Klaus and Ost, 2020). Low consumption of 2,4-dinitrophenol (DNP) (an uncoupler for mitochondrial repiration) accompanied by a healthy diet resisted obesity, protected against T2D, and prolonged longevity by approximately 7% (Caldeira da Silva et al., 2008; Geisler,

Gender dependent mitophagy in cardiovascular ageing and disease

Mitochondrial quality control and mitophagy display sex differences, culminating in distinct health outcomes. For example, mitochondrial fission enhances in brain hemispheres from females in cerebral hypoxia-ischemia, while fission overtly rises in male brain ipsilateral hemisphere. Male brain seems to exhibit more basal autophagy and mitophagy activity compared with that from females (Demarest et al., 2016). Given the apparent gender differences in metabolism and cellular primary biofuels

Targeting mitophagy for management of cardiovascular ageing; opportunities and challenges

Mitophagy maintains mitochondrial quality and removes long-lived or defective mitochondria, which prevents ageing and alleviates ageing-associated pathological phenotypes (Wu et al., 2019b). As described in previous sections, ageing dysregulates molecules involved in mitophagy, although not necessarily all mitophagy regulators. In other words, given that mitophagy is dominated by a wide network of molecules and pathways, many of them might remain intact and uninfluenced during ageing. In this

Concluding remarks

Taken together mitophagy is a cytoprotective mechanism, dysfunction of which occurs in ageing leading to cardiovascular diseases. Exploiting strategies to induce mitophagy might mitigate ageing-induced cardiovascular damages leading to improved healthspan of elderly cardiovascular patients. Despite potential molecular targets for mitophagy induction, restricting protein uptake and implementing an active lifestyle might be the easiest strategies to repel ageing-induced damage to mitochondria and

Acknowledgments

The authors would like to thank Shanghai Institute of Cardiovascular Diseases, and Zhongshan Hospital, Fudan University, Shanghai, China, and Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran for their generous support. Work in our labs has been supported by the National Key R&D Program of China (2017YFA0506000), Natural Science Foundation of China (91749128, 81770261), Science and Technology Innovation Project

References (258)

  • P. Dewing et al.

    Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation

    Molecular Brain Research

    (2003)
  • L. Du et al.

    Starving neurons show sex difference in autophagy

    Journal of Biological Chemistry

    (2009)
  • H. Erlank et al.

    Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones

    Free Radical Biology and Medicine

    (2011)
  • E.F. Fang et al.

    NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair

    Cell metabolism

    (2016)
  • J. Guo et al.

    miR-346 functions as a pro-survival factor under ER stress by activating mitophagy

    Cancer letters

    (2018)
  • J. Hu et al.

    Sirt3 regulates mitophagy level to promote diabetic corneal epithelial wound healing

    Experimental eye research

    (2019)
  • F. Jian et al.

    Sam50 regulates PINK1-Parkin-mediated mitophagy by controlling PINK1 stability and mitochondrial morphology

    Cell reports

    (2018)
  • Q. Jin et al.

    DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways

    Redox biology

    (2018)
  • J.S. Kerr et al.

    Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms

    Trends in neurosciences

    (2017)
  • S. Klaus et al.

    Mitochondrial uncoupling and longevity–A role for mitokines?

    Experimental Gerontology

    (2020)
  • S.-H. Lee et al.

    Sirtuin signaling in cellular senescence and aging

    BMB reports

    (2019)
  • S.H. Lee et al.

    Mitochondrial MsrB2 serves as a switch and transducer for mitophagy

    EMBO molecular medicine

    (2019)
  • P. Li et al.

    NR4A1 contributes to high-fat associated endothelial dysfunction by promoting CaMKII-Parkin-mitophagy pathways

    Cell Stress and Chaperones

    (2018)
  • Q. Li et al.

    Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke

    Biochemical and biophysical research communications

    (2014)
  • R. Li et al.

    Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: the role of the ERK-CREB pathway and Bnip3-mediated mitophagy

    Redox biology

    (2018)
  • Y.P. Abudu et al.

    NIPSNAP1 and NIPSNAP2 act as “eat me” signals for mitophagy

    Developmental cell

    (2019)
  • A.A. Alshudukhi et al.

    Lipin-1 regulates Bnip3–mediated mitophagy in glycolytic muscle

    The FASEB Journal

    (2018)
  • K. Araki et al.

    Mitochondrial protein E2F3d, a distinctive E2F3 product, mediates hypoxia-induced mitophagy in cancer cells

    Communications biology

    (2019)
  • M.A. Augustin et al.

    Nano‐and micro‐encapsulated systems for enhancing the delivery of resveratrol

    Annals of the New York Academy of Sciences

    (2013)
  • A. Benigni et al.

    Sirt3 Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by Opa1 Gene Transfer

    Antioxidants & redox signaling

    (2019)
  • J.P. Bernardini et al.

    Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy

    The EMBO journal

    (2019)
  • D. Bernhardt et al.

    Simultaneous impairment of mitochondrial fission and fusion reduces mitophagy and shortens replicative lifespan

    Scientific reports

    (2015)
  • A. Bitto et al.

    Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

    elife

    (2016)
  • F. Burté et al.

    Disturbed mitochondrial dynamics and neurodegenerative disorders

    Nature reviews neurology

    (2015)
  • A. Calcinotto et al.

    Cellular senescence: aging, cancer, and injury

    Physiological reviews

    (2019)
  • C.C. Caldeira da Silva et al.

    Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity

    Aging cell

    (2008)
  • A.F. Ceylan-Isik et al.

    Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy

    Basic Res Cardiol

    (2013)
  • K. Chang et al.

    TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2

    Autophagy

    (2019)
  • H. Chao et al.

    Cardiolipin-dependent mitophagy guides outcome after traumatic brain injury

    Journal of Neuroscience

    (2019)
  • F. Checler et al.

    Presenilins at the crossroad of a functional interplay between PARK2/PARKIN and PINK1 to control mitophagy: Implication for neurodegenerative diseases

    Autophagy

    (2017)
  • Y.-F. Chen et al.

    Coenzyme Q10 Alleviates Chronic Nucleoside Reverse Transcriptase Inhibitor-Induced Premature Endothelial Senescence

    Cardiovascular toxicology

    (2019)
  • Y.A. Chiao et al.

    Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice

    bioRxiv

    (2020)
  • M. Comas et al.

    New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis

    Aging (Albany NY)

    (2012)
  • N. Cummins et al.

    Disease‐associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria

    The EMBO journal

    (2019)
  • D. D’Amico et al.

    The RNA-binding protein PUM2 impairs mitochondrial dynamics and mitophagy during aging

    Molecular cell

    (2019)
  • S.-h. Dai et al.

    Notch1 protects against myocardial ischaemia‐reperfusion injury via regulating mitochondrial fusion and function

    Journal of Cellular and Molecular Medicine

    (2020)
  • S. Dalal et al.

    Exogenous Ubiquitin Attenuates Hypoxia/Reoxygenation-Induced Cardiac Myocyte Apoptosis via the Involvement of CXCR4 and Modulation of Mitochondrial Homeostasis

    Biochemistry and Cell Biology.

    (2020)
  • F. De Falco et al.

    Bovine papillomavirus E5 oncoprotein upregulates parkin-dependent mitophagy in urothelial cells of cattle with spontaneous papillomavirus infection: a mechanistic study

    Comparative Immunology, Microbiology and Infectious Diseases

    (2019)
  • C.A. De La Lastra et al.

    Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications

    (2007)
  • T.G. Demarest et al.

    Sex differences in mitochondrial (dys) function: Implications for neuroprotection

    Journal of bioenergetics and biomembranes

    (2015)
  • Cited by (0)

    View full text